Identification of TSIX, Encoding an RNA Antisense to Human XIST, Reveals Differences from its Murine Counterpart: Implications for X Inactivation  by Migeon, Barbara R. et al.
Am. J. Hum. Genet. 69:951–960, 2001
951
Identification of TSIX, Encoding an RNA Antisense to Human XIST,
Reveals Differences from its Murine Counterpart: Implications for X
Inactivation
Barbara R. Migeon,1,2 Ashis K. Chowdhury,1,2 Jennifer A. Dunston,1 and Iain McIntosh1,3
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X inactivation is the mammalian method for X-chromosome dosage compensation, but some features of this
developmental process vary among mammals. Such species variations provide insights into the essential components
of the pathway. Tsix encodes a transcript antisense to the murine Xist transcript and is expressed in the mouse
embryo only during the initial stages of X inactivation; it has been shown to play a role in imprinted X inactivation
in the mouse placenta. We have identified its counterpart within the human X inactivation center (XIC). Human
TSIX produces a 130-kb transcript that is expressed only in cells of fetal origin; it is expressed from human XIC
transgenes in mouse embryonic stem cells and from human embryoid-body–derived cells, but not from human
adult somatic cells. Differences in the structure of human and murine genes indicate that human TSIXwas truncated
during evolution. These differences could explain the fact that X inactivation is not imprinted in human placenta,
and they raise questions about the role of TSIX in random X inactivation.
Introduction
X inactivation is the mammalian method for equaliza-
tion of the dosage of X-linked genes in males and fe-
males; this is accomplished by down-regulating the tran-
scriptional output of X chromosomes in females, so that
only one X is active in diploid somatic cells of both sexes
(Lyon 1962). This transcriptional silencing is initiated
in female embryonic blastocysts and can be induced in
murine embryonic stem (ES) cells. Inactivation is man-
ifested by underacetylated histones, methylated CpG is-
lands, and delayed DNA replication, as reviewed by
Heard et al. (1997). The initial events responsible for a
single active X in mammalian cells are largely unknown,
but some players have been identified. The key control
region on the X chromosome, from which inactivation
is initiated and signals are spread, has been mapped to
Xq13.2 and is referred to as the “X inactivation center”
(XIC in humans and Xic in mouse). X chromosomes
can be programmed to inactivate because of the X in-
active specific transcript gene (XIST in human and Xist
in mouse [MIM 314670]) located within this region. The
expression of XIST starts a cascade of events that re-
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sults in silencing of the chromosome from which it is
transcribed.
Prior to the time that an inactive X is seen in female
embryos, XIST is expressed at low levels from all X
chromosomes, even from the single X in male embryos
(Ray et al. 1997). Therefore, it seems likely that an early
step in this developmental pathway is one that ensures
that the XIST locus on one X chromosome is turned
off in cells of both sexes; in this way, one and only one
X chromosome will be functional. The XIST allele that
is repressed in female cells is usually chosen randomly;
all other X chromosomes in the cell are inactivated by
default, via propagation of the XIST-induced inacti-
vating signal(s) along the chromosome. The choice is
nonrandom in mouse placental tissues, where the Xist
locus on the maternal X is always repressed; hence, the
maternal X is always active. The XIST RNA is untran-
slated and remains in the nucleus, associated with the
inactive X (Clemson et al. 1996). The stabilization and
accumulation of this RNA around the inactive X is
thought to propagate the inactivating signal along the
chromosome (Panning et al. 1997).
Clearly, XIST is not the only player in this process;
if it were, there would be no active X chromosome,
since all X chromosomes would be silenced. Something
else is needed to repress the XIST locus on the active
X in both sexes. The X controlling element (Xce), a
locus downstream of murine Xist, affects the random-
ness of inactivation in a manner not yet known (Simmler
et al. 1993). The orthologous locus has not been iden-
tified on the human X chromosome. In addition, Lee et
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Figure 1 PipMaker percent identity plot of the human XIC region in ES-10, showing the location of a novel transcript and homology
to the comparable region in the murine genome. Nucleotides 0–80000 of the U80460 sequence (0–80 kb) are shown. Plotting of XIST exons
(orange) is based on all known transcribed sequences (Brown et al. 1992; Hong et al. 2000). The black dot pattern shows the percent homology
(50%–100%) with the comparable mouse Xic region. The XIST transcript is shown as a solid line with an arrow. The TSIX transcript (dotted
line with arrow) is antisense to XIST and is initiated from four clustered transcription start sites, the most 5′ of which shown (see fig. 3). The
purple vertical bar in XIST exon 1 represents the single CpG island identified by the Grail program (version 1.3). The small blue boxes indicate
a CpG:GpC frequency of .6; the one near the TSIX start site is marked by a blue arrow. The locations of RT-PCR primers (a–cc) are shown
in lowercase letters. The lack of homology outside of the XIST region has also been documented in a PipMaker plot by Nesterova et al. (2001,
fig. 5e). MIR p mammalianwide interspersed repeats; SINE p short interspersed elements.
al. (1999) discovered Tsix (MIM 300181), the gene en-
coding an RNA that is, in part, antisense to the murine
Xist transcript. Tsix was initially described as a 40-kb
transcript starting downstream of Xist and overlapping
the entire Xist locus. More recently, Sado et al. (2001)
have found a processed Tsix transcript in murine ES
cells. Like Xist, Tsix has no open reading frames
(ORFs), and its RNA is found in the nucleus. However,
unlike Xist, the Tsix RNA is associated with the future
active X. There is some evidence that the Tsix transcript
may be an antagonist of Xist. Studies of mice carrying
a Tsix deletion show that Tsix is required for repression
of the maternal Xist allele in placental tissues where the
paternal X chromosome is preferentially silenced. Lee
(2000) and Sado et al. (2001) have proposed that Tsix
is the maternally expressed factor that protects the ma-
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ternal X from imprinted X inactivation in extra-em-
bryonic tissues. The role of Tsix in random inactivation
remains to be elucidated (this will be discussed below).
We recently showed that it was feasible to study the
human XIC region through use of human transgenes
introduced into murine ES cells, as well as through chi-
meric mice derived from them. Six tandem copies of one
transgene with 480 kb of the human XIC region, in-
cluding the XIST locus, inserted into mouse chromo-
some 11 was able to induce random X inactivation in
male chimeric mice, resulting in inactivation of the mu-
rine X chromosome in some XY cells carrying the trans-
gene (Migeon et al. 1999). The other, a single-copy
transgene with !300 kb of the human XIC region car-
ried on mouse chromosome 6, was recognized as an
XIC in male ES cells but could not induce inactivation
in mice (Migeon et al. 2001), presumably because of
the low copy number (Heard et al. 1999). UnlikeXIST/
Xist, which is expressed in all cells with an inactive X
at any age, murine Tsix is expressed only transiently,
prior to and during the time that X inactivation is being
established. Murine ES cells recapitulate the stages of
X inactivation seen in the mouse embryo proper (Lee
and Lu 1999) and are an accepted model for studies of
this developmental process. Therefore, to determine
whether there was a human gene orthologous to Tsix,
we looked for other human transcripts in the mouse ES
cells carrying the human XIC transgene. As a result, we
have identified a transcript that is antisense toXIST and
overlaps the XIST locus at its 3′ end. This transcript is
also present in human-embryo–derived stem cells but is
absent from adult somatic cells. On the basis of our
observations, we suggest that human TSIX is not in-
volved in genomic imprinting and may not be an an-
tagonist of human XIST expression.
Material and Methods
Transgenes and Cell Lines
Mouse ES cells carrying the ES-10 and ES-5 transgenes
were derived from mouse J1 ES cells and have been
reported elsewhere (Migeon et al. 1999, 2001). ES-10
contains six copies of the full transgene, and ES-5 con-
tains a single copy of a truncated one. In addition, we
studied XY somatic cells from chimeric mouse embryos
949.1 and 850.3, which carry the ES-10 and ES-5 trans-
genes on autosomes and are hereafter referred to as
“ESch10” and “ESch5,” respectively. The murine ES cell
transfectants were kept undifferentiated on feeders in
medium with leukemia inhibitory factor (LIF). For dif-
ferentiation, they were passaged twice without feeders
on gelatinized dishes in the presence of LIF and then
were cultured in suspension without LIF, for aggregation
into embryoid bodies (EBs).
The human embryonic cells used for analysis were
four genetically distinct cell lines originating from pri-
mordial germ cells at 5–11 wk postfertilization (pf).
These fibroblast cultures were established from human
EBs by J. Gearhart and are referred to as human “em-
bryoid-body–derived” (EBD) cells. They are no longer
totipotent but do transcribe some genes that are ex-
pressed early in development (Shamblott et al. 2001).
Cell lines LV (5 wk pf) and SD (11 wk pf) were 46, XX,
whereas SL (6 wk pf) and LU2 (7 wk pf) were 46, XY.
Our use of the human EBD cells was approved by the
university committee concerned with patents and by
Geron, Inc., according to the licensing agreement. They
were maintained in EGM2MV medium on collagen
plates, as described by Shamblott et al. (2001).
RNA Analysis
Primers.—XIST is oriented in the opposite direction
of the mouse gene, so that the 3′ XIST is closest to the
centromere. Both the ES-10 and ES-5 transgenes include
the ∼50-kb human XIST locus and ∼70 kb centromeric
(proximal) to the 3′ end of XIST. They differ in the
amount of sequence telomeric (distal) to the 5′ end of
XIST (360 kb for ES-10 and !180 kb for ES-5). Sequence
data for both transgenes are provided in PAC 92E23
(GenBank), which has been sequenced in two parts,
found under GenBank accession numbers U80459 and
U80460. The locations of primers used for RNA analysis
are shown in figure 1 and table 1 and are based on the
U80460 sequence. Specific primer sequences will be pro-
vided on request.
Reverse-Transcriptase PCR.—RNAwas obtained from
ES cells before and after differentiation into EBs. Total
RNAwas isolated with TRIZOL (Life Technologies) and
treated with DNaseI (at 37C for 1 h). Poly A RNA
was isolated using the Nucleotrap mRNA separation kit
(Clontech). To screen for transcripts, reverse-transcrip-
tase PCR (RT-PCR) was performed (1 mg RNA, 35 cy-
cles; Migeon et al. 1999). The cDNA was generated
using random priming for sequences outside the XIST
transcription unit, whereas strand-specific priming was
used for the portion of TSIX that overlaps XIST.
For strand-specific RT-PCR, first-strand cDNA was
synthesized using either sense or antisense primers, as
described by Lee et al. (1999), with minor modifications.
RNA (0.5–1 mg) with strand-specific primer (3 pmol)
was incubated at 70C for 5 min and then was equili-
brated to 50C. The cDNA was synthesized with Su-
perscript II reverse transcriptase (200 U, Life Technol-
ogies) at 50C for 1 h. The RT was heat-inactivated at
80C for 45 min. After treatment with RNaseH (Life
Technologies), first-strand cDNA was amplified with
Taq polymerase for 35 cycles, using paired sense and
antisense primers. Controls containing RNA and strand-
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Table 1













ES-10 ES-5 SD LV
a (.3 kb)     
b (XIST-pro) / / /  / /
c (5’ XIST) / / / ND /
d (XIST-ex1) / / / / /
e (XIST-int3)     
f (XIST-ex4) / / / / /
g (XIST-int4) ND/ ND/ ND/ ND/ ND/
h (XIST-ex5) / / / / /
i (XIST-ex6) / / / / /
j (3’ XIST) / / / / /
k (53 kb)     
l (55 kb)    ND ND
m (57 kb) / / /  
n (58 kb)     
o (61 kb)    ND ND
p (62 kb)    ND ND
q (65 kb)     
r (68 kb)    ND ND
s (69 kb)    ND ND
t (69.8 kb)     
u (70.4 kb)   ND ND ND
v (70.8 kb)     
w (72.6 kb)     
x (74.5 kb)   ND  
y (75.5 kb)     
z (77.4 kb) / / /  
aa (77.8 kb)     
bb (78.2 kb)     
cc (79 kb)    ND ND
NOTE.—Controls (human male and mouse J1 ES cells) were
negative for each primer set.  p product present; p product
absent. A single symbol indicates a result of random priming of
cDNA, and two symbols (i.e., /, /, or /) indicate sense/
antisense (XIST/TSIX), the results of strand-specific priming. ND
p not done.
a Primers are shown in figure 1. Values shown in kilobases in-
dicate the position in U8046. Prop promotor, exp exon, intp
intron.
specific primer but no reverse transcriptase were proc-
essed in parallel.
5′ Rapid Amplification of cDNA Ends (RACE).—Total
RNA (10 mg) was treated with RNase-free DNaseI (Am-
bion). 5′ RACE (was performed using the GeneRacer
kit (Invitrogen), according to manufacturer instructions.
First-strand cDNA was primed with a gene-specific
primer (U80460 nucleotides (nt) 77426–77443), was ex-
tended with Superscript II at 42C for 50 min and was
treated with RNaseH. 5′ ends were amplified using the
GeneRacer 5′ primer and a gene-specific primer (U80460
nt 77565–77588). Nested PCR was performed with the
GeneRacer 5′ nested primer and two gene-specific prim-
ers (U80460 nt 77578–77603 and U80460 nt 77678–
77704). PCR products were either gel purified or were
cloned into the pCR4-TOPO vector (Invitrogen) and
were sequenced using [33P]-labeled chain terminators
(Thermo Sequenase Cycle Sequencing Kit, USB).
Sequence Analysis
Once identified, the TSIX sequence from U80460
(GenBank) was analyzed for CpG islands, using the
Grail program (version 1.3; Oak Ridge National Lab-
oratory Web site). Potential TATA boxes were identified
using the HCtata program on the WebGene server. Only
strong consensus sequences were considered. We as-
sembled the mouse Xic sequence (GenBank accession
numbers AJ010350, M97167, L04961, U41394, and
X999460) through use of Sequencher software and com-
pared it to the human XIC sequence (U80460). Both
strands were searched for homology by the Advanced
PipMaker (Schwartz et al. 2000; PipMaker Web site).
The human sequence was masked using the Repeat-
Masker program (RepeatMasker Web site). Percent
identity plot (PIP) and dot plot graphics from the Ad-
vanced PipMaker were modified in Adobe PhotoShop,
for clarity of presentation.
Results
Search for Transcripts from the Human XIC Transgene
in Mouse ES Cells
Both human XIC transgenes include nt 1–119,000 of
the U80460 sequence; the XIST transcription unit ex-
tends from nt 18317 to 50425 (Brown et al. 1992; Hong
et al. 2000). Initially, we looked for novel transcripts,
using RT-PCR primers at 10-kb increments, starting
from U80460 nt 1–119000 (70 kb proximal and 18 kb
distal to XIST). We also used primers at the distal end
of U80459 (50 kb upstream of the 5′ end of XIST), a
region also present in both ES-10 and ES-5 cells.
Figure 1 is a PipMaker PIP (Schwartz et al. 2000)
showing the U80460 portion of ES-5 and ES-10 trans-
genes that includes XIST and the only other transcript
identified in the region. RT-PCR analysis using cDNA
obtained by random priming showed that the novel tran-
script originates ∼27 kb from the 3′ end of XIST. Table
1 shows that it extended as far as XIST exon 5; RT-
PCR results were positive with primer set h but negative
with primer set g, 600 bp upstream in XIST intron 4.
The primers that gave negative results in the RNA anal-
ysis were positive in the DNA analysis of the same cells.
This transcript was not seen in any of the control cells
(human male and female or parental J1 ES cells).
Novel Transcript Is Antisense to XIST
Strand-specific priming of the cDNA showed that this
transcript was present in poly A RNA. This transcript
was antisense to XIST, since it was amplified from the
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Figure 3 Identification of TSIX transcription start sites in ES-
10 cells. Transcription start sites (arrows) were determined by 5′ RACE
using ES-10 as template. The TSIX transcript is initiated from four
clustered transcription start sites (bases 77657, 77865, 78267, and
78860 in the U80460 sequence). The location of repetitive elements
are indicated as follows: black vertical lines denote Alu elements, gray
boxes denote LTRs, diagonal lines denote LINE elements, and hori-
zontal lines denote MER1 elements.
Figure 2 Strand-specific RT-PCR showing polyadenylation and
orientation of transcripts. Top, Sense (XIST) transcript (cDNA syn-
thesized using reverse primer). Bottom, Antisense (TSIX) transcript
(cDNA synthesized using forward primer). RNA samples were total
RNA, unless otherwise indicated. Lane 1, 100-bp marker; lanes 2 and
3, male; lanes 4 and 5, female; lanes 6–9, ES-10; lanes 10 and 11,
human EBD LV cells; lanes 12 and 13, J1, mouse ES cell control.
Samples were assayed using primer set g in the presence () or absence
() of reverse transcriptase (RT). Note that ES-10 and LV cells have
both sense and antisense transcripts with XIST exon 6 primers.
cDNA primed by the forward primers (relative toXIST)
and not from that primed by the reverse primers (fig.
2). Strand-specific priming also showed that this anti-
sense transcript overlapped the XIST transcript, extend-
ing from 3′ XIST through exon 5 (table 1 and fig. 1).
Because this novel transcript is transcribed from the op-
posite strand as human XIST and overlaps XIST, we
believe that it is the counterpart of murine Tsix; there-
fore, we will subsequently refer to this gene as “TSIX.”
Despite numerous attempts, we have obtained little
evidence of a processed TSIX transcript. Using a large
number of closely spaced primers, which in the TSIX
unique region were 0.1–3 kb apart, with an average
interval of 1.15 kb (fig. 1), we found a contiguous tran-
script. We did identify a small intron (763 bp) at the
start of the transcript in ES-10 (fig. 3; discussed below).
In addition, no small transcripts were detected on north-
ern blots.
TSIX Has No ORF
The coding potential of the TSIX transcript was in-
vestigated in silico. The sequence from nt 30000 to nt
80000 of U80460 (complementary strand) was analyzed
using ORFGene (Rogozin et al. 1996; ORFGene 2 Web
site) and GeneBuilder (Milanesi et al. 1999; GeneBuilder
Web site) software. ORFGene did not identify any ORFs
in this interval. GeneBuilder predicted a series of exons
across the interval, which were inconsistent with the re-
sults of RT-PCR analysis (table 1 and data not shown).
The predicted ORF lacked an initiation codon and
showed no homology to any protein in the SWISSPROT
database.
TSIX Has Little Homology to Tsix
Figure 1, which is based on the GenBank sequence,
shows the homology between the human and mouse
DNA sequence in theXIST-TSIX region. There aremany
repeats within this region. Virtually all the significant
homology (150%) lies within the XIST locus. The only
150% homology in the region of the TSIX transcript is
minimal and is limited to a single region at ∼76 kb, near
the start of the TSIX transcript in ES-10; this is most
likely the region of human homology to mouse Tsix
observed by Lee et al. (1999, fig. 6).
Identification of TSIX Transcription Start
5′ RACE was used to define the 5′ boundary of the
TSIX transcript in ES-10 cells (fig. 3). Four transcription
start sites were identified, at nt 77657, 77865, 78267,
and 78860 of U80460. The first three start sites are
located within repetitive elements MER58B, AluY, and
L2, respectively. Transcription from positions 78860 and
77865 may be directed by TATA box sequences within
the repeats. An additional upstream exon was identified
in the 78860 transcript. The alternate first exon is 23
bases in length, followed by an intron of 763 ba-
ses—perhaps the remnant of the small intron between
murine Tsix exons 2 and 3 (Sado et al. 2001). Splice
sites conform to consensus sequences (Shapiro and Sen-
apathy 1987).
Evidence that Human TSIX is Truncated Relative to
Tsix
On the basis of the results of 5′ RACE studies and
homology searches, the start sites in the human gene are
at what may be analogous to Tsix exons 2 and 3 in the
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Figure 4 Dot plot showing the evolutionary breakpoint within
the human XIC. The region shown is an extension of that in figure 1
and includes the region from 0–136 kb of U80460. The dark gray bars
represent the XIST exons; the light bar shows the CpG island in XIST
exon 1 (asterisk). The effective evolutionary breakpoint is shown as
occurring at the start of the TSIX transcript; the actual breakpoint is
difficult to determine. The areas circled and numbered 1–3 show the
only conserved regions outside of the XIST gene. Region 1 is homol-
ogous to murine Tsix, and regions 2 and 3 are homologous to the
murine testis gene (Tsx) exons 5 and 4, respectively, which are sepa-
rated in the human genome by ∼40 kb. This figure, a PipMaker dot
plot comparing human and mouse XIC sequences, is similar to the
traditional dot plot of this region, shown by Lee et al. (1999, fig. 6);
however, we now know that regions 2 and 3 are homologous to TSX
and not TSIX.
mouse (Sado et al. 2001) (see region with homology in
fig. 1). Unlike murine Tsix, which has a CpG island at
its 5′ end (Lee and Lu 1999), the human TSIX gene lacks
a proper CpG island (fig. 1). A search of the U80460
sequence by the Grail program (version 1.3) revealed
only a single CpG island—the one that overlaps the 5′
end of XIST (nt 19545–19756; see figs. 1 and 4). Only
a small CpG-rich region remains near the TSIX start site
(fig. 1, arrowed blue box).
To insure that the absence of a CpG island from the
5′ end of TSIX is not an artifact, the U80460 sequence
was compared to that obtained from a whole-genome
shotgun assembly of genomic DNA from five unrelat-
ed individuals (Venter et al. 2001; Celera Web site).
The sequences obtained from the two data sets are co-
linear over the entire length of U80460, exhibiting
99.96% identity, with the largest discrepancy being a
10-bp insertion/deletion within a pentanucleotide re-
peat sequence.
The lack of the expected CpG island at the start of
TSIX suggested an evolutionary breakpoint. Evidence of
this comes from the analysis of a neighboring gene. The
X-linked testes specific gene (Tsx), which resides within
7 kb of murine Tsix (Sado et al. 2001), is expressed in
rodent testes but has no counterpart expressed in human
testes (Simmler et al. 1996). In fact, there is no human
ortholog, since only homologous fragments of mouse
Tsx are present in the human genome. Human TSX se-
quences are scattered in the humanX chromosome: exon
1 is in Xq23 and exon 6 is in Xq21. Remnants of exon
5 and exon 4 are present within U80460, but these frag-
ments are 13–20 kb and 150 kb from the 5′ end of TSIX,
respectively (areas 2 and 3, respectively, of fig. 4).
TSIX is Transcribed in Human Embryonic Cells
Because transcripts expressed from our human trans-
gene could have been artifacts of transfection, we were
encouraged by the preliminary evidence of a low-level
antisense transcript originating “downstream of XIST
exon 8 and extending only into the 3′ end of XIST” in
the NT2 human embryonal carcinoma line derived from
a testicular teratocarcinoma (Chow et al. 2000). To find
the TSIX transcript that was not present in adult human
cells, we chose to examine fetal cells derived fromhuman
EBs (Shamblott et al. 2001). To determine the X inac-
tivation status of these cells, we assayed them for XIST
transcripts. The two female human EBD cell lines (SD
and LV) expressed XIST, but the male human EBD lines
(SL and LU2) did not. Since XIST is expressed in male
blastocysts prior to the time of X inactivation (Ray et
al. 1997), SL and LU2 have passed the developmental
stage when XIST is expressed. Therefore, both male and
female EBD cell lines were at a stage subsequent to the
onset of X inactivation.
Since X inactivation had already occurred in these
cells, we were surprised to find the TSIX transcript in
the two female EBD lines. In both of them, the transcript
was ∼3.8–5.6 kb shorter than that found in ES–10 cells.
The start site was difficult to determine, because of the
density of repeated sequences in this region (fig. 1), but
transcription of TSIX most likely originates between nt
73254 and nt 75031 of U80460. The repeated sequences
also made it difficult to design primers for 5′ RACE.
Since primers within the unique sequence failed to gen-
erate RACE products, it is difficult to determine the
TSIX transcription start site in the human EBD cells
more precisely. On the other hand, our analysis shows
that the 3′ end of the TSIX transcript was identical to
that in ES-5 and ES-10 cells, since it extended only as
far as XIST exon 5 (table 1).
TSIX is Transcribed in Mouse Embryonic Fibroblasts
Carrying the Human Transgene
We examined ESch5 and ESch10 fibroblasts originat-
ing from 13.5-d and 18-d embryos chimeric for the ES-
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5 or ES-10 transgenes. Both cell lines expressed not only
XIST, but also TSIX . Assayed with TSIX-specific primer
sets l, n, o, t, w, aa, bb, and cc (see fig. 1), these fibroblasts
had RT-PCR products with all primer sets except cc,
indicating the same expression pattern as the ES trans-
fectants from which they were derived (cf. ES-5 and ES-
10; table 1).
Characteristics of TSIX Expression in Embryonic Cells
According to observations of Lee et al. (1999) and
Sado et al. (2001), murine Tsix is not present in eight-
cell embryos, is expressed in blastocysts from both X
chromosomes before X inactivation, and is expressed at
the onset of inactivation only from the allele on the active
X. Tsix expression disappears from ES cells during the
2–9 d following their differentiation into EBs. In chi-
meras, the level of expression is greater in the placenta
than in the fetus proper and is absent from both by
12–15 d of gestational age. The expression of human
TSIX seems to persist longer, at least in a mouse envi-
ronment, since it is found in ES-10 cells long after their
differentiation into EBs (at least to the 19th passage after
differentiation) and in the fetal somatic cells derived
from 18-d and 13.5-d ES-10 and ES-5 chimeric fetuses,
at a time when murine Tsix transcripts are minimal or
no longer expressed.
Another difference has to do with lack of evidence
that human TSIX influences XIST expression. In the
female embryo-derived cells, TSIX transcripts were
coexpressed with those from XIST, so that human TSIX
expression did not repress the expression of XIST. Since
the male embryo-derived cells did not express TSIX, the
transcript is not associated with active X chromosomes
in males. Coexpression was also seen in the ES-10 and
ES-5 EBs and their chimeric mouse derivatives. In this
case, both human transcripts had to come from the
transgene, and, hence, from the same chromosome.
Discussion
Comparing Human TSIX with Murine Tsix
The results of our analysis show that human TSIX,
like its murine counterpart, is expressed only in embryo-
derived cells, initiates downstream of the 3′ end ofXIST,
and produces an untranslated RNA. This RNA is tran-
scribed from the opposite strand as XIST and is, in part,
antisense to XIST. However, the human TSIX gene dif-
fers from its murine counterpart in that it is truncated
at the 5′ end, does not cover the XIST promoter, and
does not have the CpG island that is essential for func-
tion of murine Tsix.
The mouse Tsix gene was originally described as a 40-
kb RNA without introns, originating 15 kb downstream
of Xist and transcribed across the Xist locus. More-re-
cent studies indicate that it is at least partially processed,
giving a 2.7-kb transcript originating from the major
promoter located near Tsix exon 2. Sado et al. (2001)
also found a 4.3-kb transcript originating from the mi-
nor promoter, located ∼28 kb downstream of Xist, sug-
gesting that Tsix starts 13 kb further downstream than
originally reported. In addition, these investigators show
that exon 2 is associated with a CpG island, which is
known to be differentially methylated on active and in-
active chromosomes (Prissette et al. 2001). Although the
human TSIX transcripts from ES-10 and ES-5 cells also
begin ∼27 kb downstream of XIST, they have a much
shorter overlap with XIST, ending in exon 5; they do
not overlap the 5′ end of the gene (table 1). The only
transcript found in ES-10 in the region of the XIST pro-
moter was shown by strand-specific RT-PCR to be at-
tributable to XIST and not TSIX (table 1 and data not
shown). Therefore, the TSIX transcript in ES-5 and ES-
10 cells is ∼35 kb in length. The TSIX transcript from
human EBD cells has the same limited overlap but is
3.8–5.6 kb shorter; this difference may reflect the influ-
ence of the mouse environment on expression of the
human transgenes.
Analysis of TSIX Identifies XIC Breakpoint
All of our evidence suggests that the 5′ end of the
human TSIX locus may have been decapitated by an
evolutionary breakpoint. The existence of an XIC in
Xq13 was originally postulated on the basis of the con-
served order of genes on murine and human X chro-
mosomes. However, subsequent studies have revealed
many microrearrangements in this region, including an
inversion, which affects the transcriptional orientation
of the XIST locus (Brockdorff et al. 1992). Although
the exact site of the breakpoint cannot be determined,
it is clear that there was an evolutionary change in the
human TSIX region that resulted in loss of the human
counterpart of the mouse testes-specific gene (Tsx) distal
to murine Tsix. This breakage event shattered the TSX
gene, spreading exons throughout the long arm of the
X chromosome in the ancestor who gave rise to the
human population. The extraordinary distance between
TSX exons 4 and 5 has also been observed by Nesterova
et al. (2001, fig. 5e). This breakpoint at ∼27 kb from
human XIST probably defines one boundary of the es-
sential XIC in both species (indicated by an arrow in
fig. 4).
An important question is whether this breakpoint in-
fluences the function of TSIX or the process of X in-
activation. Some insights come from deletions in the mu-
rine Tsix gene, induced by Sado et al. (2001). Disrupting
Tsix exon 1 (located ∼28 kb from murine Xist)—but
not the CpG island (∼14 kb fromXist)—neither affected
the second promoter nor interfered with Tsix function.
However, the deletion in the Tsix exon 2 region, in-
cluding part of the CpG-rich region, blocked Tsix tran-
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scripts running across the Xist gene, which these inves-
tigators suggest is responsible for the loss of Tsix
function. In addition, the targeted (3.5-kb) deletion by
Lee (2000) of this CpG island also disrupted imprinted
X inactivation. The evolutionary breakpoint in human
TSIX not only eliminated exon 1 and most likely part
of exon 2, but also resulted in the loss of most of the
CpG-rich region near the start of TSIX, either directly
or through evolutionary drift. The lack of significant
homology over the TSIX region (figs. 1 and 4) and the
large number of repetitive sequences—mostly long tan-
dem repeats (LTRs) (figs. 1 and 3) not seen in the murine
Tsix region (data not shown)—suggest that significant
drifting has occurred. In any case, although the exon 1
deletion may not interfere with TSIX function, it seems
likely that elimination of the CpG island would interfere
with parental imprinting.
Significance of Species Differences with Respect to X
Inactivation
There are many ways to compensate for sex differ-
ences in X gene dosage; compensatory mechanisms are
directed at transcription and range from up-regulating
the transcriptional output of the single X in males to
down-regulating that of the X chromosomes in females.
However, only mammals compensate by X inactivation.
Since both marsupials and placental mammals use X
inactivation, the basic mechanisms should be the same
for all mammals. Therefore, features of X inactivation
that differ among mammals are merely variations on the
basic theme (Migeon 1990). These species variations tell
us which details of the X inactivation scheme are not
essential for establishing a single active X in mammalian
cells. Such variable features include time of onset, choice
of active X (either random or maternal), and stability
of inactivation once established. Variations affecting sta-
bility result from differences in the DNA methylation
status of CpG islands on the inactive X chromosome
(Migeon 1990). Most likely, differences in the time of
onset are responsible, at least in part, for the paternal
(imprinted) inactivation in marsupials and in placental
tissues of rodents and for the well-documented lack of
imprinted X inactivation in human placental tissues
(Migeon and Do 1978, 1979; Migeon et al. 1985, 1986;
Mohandas et al. 1989; van den Hurk et al. 1997). Other
variable features include theXIST locus itself, which has
undergone inversion event(s) during mammalian evo-
lution and whose DNA sequence is so poorly conserved
among mammals that the marsupial gene has not yet
been identified. Such species differences in the details of
X inactivation reflect variations that do not interfere
with the basic process responsible for the single active
X.
What do our studies reveal about the role of Tsix/
TSIX in imprinted X inactivation? On one hand, they
support the notion that murine Tsix plays a role in im-
printed X inactivation in mice, perhaps as a factor to
block Xist expression on the maternal X chromosome.
Studies of knockouts of the mouse Tsix locus clearly
show that it has a role in paternal X inactivation in the
placenta; Tsix deletions carried on the maternal X lead
to silencing of the maternal as well as the paternal X
chromosome in many cells, resulting in placental ab-
normalities and fetal death (Lee 2000; Sado et al. 2001).
On the other hand, along with the lack of paternal X
inactivation in human placental tissues, the evolutionary
changes we observe suggest that human TSIX does not
share this function. The structural features of the murine
Tsix locus seem to be suited to its imprinting function.
Like many imprinted genes, Tsix is initiated near a CpG
island that is differentially methylated; it produces an
antisense transcript, which, whether processed or not,
overlaps the promoter of its target gene and is monoal-
lelically expressed from the opposite chromosome as
Xist. The nature of the interaction between the antisense
transcript and its target is not yet known, and the pos-
sibility that the abbreviated human TSIX transcript in-
teracts with XIST at the critical moment in development
cannot be excluded. However, the fact that the human
gene is a truncated version of the murine one has im-
plications for its function. Because the human transcript
does not cover the XIST promoter, the means by which
it interacts withXIST cannot involve direct physical con-
tact with the promoter. In addition, since TSIX lacks the
differentially methylated CpG island, which, when de-
leted in the mouse gene, disrupts imprinted X inacti-
vation, it probably cannot imprintXIST expression. Fur-
ther, we obtained no evidence that human TSIX inhibits
XIST expression; the fact that TSIX and XIST are tran-
scribed simultaneously from the same transgene in ES-
10 and ES-5 cells suggests that it does not.
Jacob (1977) has suggested that Mother Nature is
more tinkerer than engineer and that she uses materials
at hand to modify her work. Tsix in mice—and, perhaps,
a comparable RNA in marsupials—may have been used
to reinforce the parental imprinting needed because of
the earlier onset of X inactivation in these species. In
any case, our observations could explain why X inac-
tivation is not imprinted in human placental tissues.
The role of Tsix in the basic scheme of random (non-
imprinted) X inactivation is less clear. Tsix knockouts
do skew the patterns of X inactivation in the embryo
proper, since the chromosome bearing the deletion is
exclusively the inactive one. However, the effect of a
knockout of Tsix function on random (nonimprinted)
X inactivation must be distinguished from its effect on
imprinted inactivation in the placenta. In addition, a
nonspecific effect of the deletion on Xist function, un-
related to antisense function, cannot be excluded. In fact,
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Morey et al. (2001) studied mice carrying a 65-kb de-
letion that removed all of Tsix except that which over-
laps Xist and which was associated with exclusive in-
activation of the deleted X. They showed that restoration
of Tsix function represses Xist RNA accumulation in cis
but does not restore random inactivation. These inves-
tigators suggest that although Tsix represses the initia-
tion of X inactivation in cis, it is insufficient for normal
random choice. Conceivably, human TSIX is an evo-
lutionary relic of the murine gene, which continues to
be expressed in fetal tissues, in much the same way that
XIST continues to be expressed long after the critical
time in development—because its expression does no
harm.
In addition, it is unlikely that any cis-acting X-linked
gene could, by itself, bring about the initial choice of
the single active X. The existence of a trans-acting factor
to blockXIST expression was postulated by Lyon (1996)
and others before the discovery of Tsix. Evidence from
triploid cells (Jacobs et al. 1979; Migeon et al. 1979)
suggests that the factor(s) needed to induce the silencing
of XIST on a single X chromosome in each cell most
likely operates in trans and is autosomal in origin. In
the presence of a trans-acting factor to repress XIST
expression on the active X and DNAmethylation to lock
in the silence of the locus, Tsix would not be essential
to the inactivation process but would merely reinforce
the repression of maternal Xist in the species in which
it is needed.
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